Skip to main content icon/video/no-internet
Asthma is an obstructive airway disorder characterized by reversible airway narrowing, mucus hypersecretion, chronic inflammation, and episodic shortness of breath. Severe recurrent bouts of asthma lead to airway scarring, termed remodeling, which is not reversible and can lead to an increased frequency and severity in asthma exacerbations and lung infections. Asthma can be allergen provoked, which is termed atopic, or asthma may be due to unknown factors and termed intrinsic. There is a broad consensus that the prevalence of asthma has increased dramatically in most industrialized countries over the past several decades, prompting the development of several asthma study cohorts that have attempted to address asthma incidence, etiology, prevention, and control. What has come to be appreciated in the past decade due to the use of conditional gene expression systems, and transgenic animals, is the true complexity of the multiple molecular pathways that are involved in the development and progression of asthma and the understanding that asthma is more accurately characterized as a collection of diseases comprising a syndrome rather than a distinct homogenous entity. Therefore, in terms of a cure, there is no single ‘magic bullet’ with regard to the treatment or the prevention of asthma.

Incidence, Prevalence, and Cost Burden

In 2004, the incidence of asthma worldwide was estimated at 300 million people, and it was predicted that by the year 2025, this number would increase to 400 million. In the United States, it has been estimated that as many as 11% of the population may be afflicted. Asthma often develops in childhood, although incident adult cases are not uncommon. Estimates indicate that 28% to 78% of young children with asthma ultimately have symptom resolution once adulthood is reached, while 6% to 19% continue with severe forms of the disease. Asthma is the third leading cause of hospitalization among persons less than 18 years of age in the United States, and according to the Centers for Disease Control and Prevention, the prevalence of asthma among U.S. children increased from 3.6% in 1980 to 5.8% in 2003. Not surprisingly, there is a significant cost burden associated with health care for asthma. In 2002, the total direct medical costs relating to asthma were estimated to be $9.4 billion, with indirect costs comprising an additional $4.6 billion. Of these direct costs, 33.0% were due to hospitalization, and 39.4% were related to prescription drug costs.

Diagnosis

Asthma is a complex disease to diagnose with a single parameter. The definitive diagnosis of asthma is a clinical one made on the basis of a patient's medical history, physical examination, and assessment of the reversibility of airway obstruction. In most studies, questionnaires are used to assess whether subjects have had symptoms of asthma or have ever received a diagnosis of asthma from a physician. This type of assessment is highly subjective to a patient's and a physician's understanding and awareness of asthma and has brought speculation as to whether the number of asthma cases has really increased so dramatically or whether there is simply a higher public awareness of

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading